Teva Pharmaceutical Industries (TEVA) Equity Income (2009 - 2026)
Teva Pharmaceutical Industries (TEVA) posted Equity Income of $2 million for Q2 2026, compared with -$1 million a year earlier.
Powered by 
Analysis
Teva Pharmaceutical Industries (TEVA) Equity Income (2009 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Equity Income at Teva Pharmaceutical Industries was $14 million, up 833.3% year-over-year; for FY2025, it was $15 million.
- Annual Equity Income shows a five-year compound annual growth rate of -35.8% (FY2020 to FY2025).
- In prior years, Teva Pharmaceutical Industries' Equity Income was $1 million in FY2024 (-50.0%), $2 million in FY2023 (-90.5%), $21 million in FY2022 (+133.3%) and $9 million in FY2021 (-93.5%).
- Quarterly Equity Income has run from a low of -$5 million in Q3 2021 to a high of $21 million in Q1 2022 over five years.
- According to Business Quant data, Equity Income for the three prior quarters was -$1 million (Q1 2026), $11 million (Q4 2025) and $2 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,109.83 Bn | 1,078.42 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 610.61 Bn | 529.14 Bn | 17.26 Bn | - |
| 3 | AbbVie | 500.66 Bn | 473.77 Bn | 12.70 Bn | - |
| 4 | Merck | 354.64 Bn | 309.02 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 291.14 Bn | 255.13 Bn | 11.24 Bn | -2.00 Mn |
| 6 | Astrazeneca | 254.18 Bn | 227.87 Bn | 12.86 Bn | -10.00 Mn |
| 7 | Amgen | 229.46 Bn | 184.86 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 190.33 Bn | 164.53 Bn | 6.22 Bn | - |
| 9 | Pfizer | 167.92 Bn | 114.57 Bn | 10.94 Bn | - |
| 10 | Teva Pharmaceutical Industries | 48.14 Bn | 34.98 Bn | 2.15 Bn | 2.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.00 Mn |
| Mar 31, 2026 | -1.00 Mn |
| Dec 31, 2025 | 11.00 Mn |
| Sep 30, 2025 | 2.00 Mn |
| Jun 30, 2025 | -1.00 Mn |
| Mar 31, 2025 | -500,000.00 |
| Sep 30, 2024 | 3.00 Mn |
| Jun 30, 2024 | 2.00 Mn |
| Mar 31, 2024 | -4.00 Mn |
| Dec 31, 2023 | 1.00 Mn |
| Jun 30, 2023 | 1.00 Mn |
| Mar 31, 2023 | 500,000.00 |
| Dec 31, 2022 | 1.00 Mn |
| Sep 30, 2022 | -1.00 Mn |
| Mar 31, 2022 | 21.00 Mn |
| Sep 30, 2021 | -5.00 Mn |
| Jun 30, 2021 | 11.00 Mn |
| Mar 31, 2021 | 3.00 Mn |
| Dec 31, 2020 | 3.00 Mn |
| Sep 30, 2020 | 136.00 Mn |
API Access
Teva Pharmaceutical Industries Equity Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=equity-income&ticker=TEVA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "equity-income", "ticker": "TEVA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=equity-income&ticker=TEVA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();